Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry

OBJECTIVES: The objectives of this study were to describe the demographic profile and baseline disease characteristics of patients with psoriatic arthritis (PsA) treated with either infliximab (IFX), subcutaneous golimumab (GLM) or ustekinumab (UST) treatment in Canadian routine care setting along w...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Proton, Arendse, Regan, Khraishi, Majed, Sholter, Dalton, Sheriff, Maqbool, Rampakakis, Emmanouil, Lehman, Allen J, Nantel, Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430557/
https://www.ncbi.nlm.nih.gov/pubmed/32792436
http://dx.doi.org/10.1136/bmjopen-2019-036245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430557/
https://www.ncbi.nlm.nih.gov/pubmed/32792436
http://dx.doi.org/10.1136/bmjopen-2019-036245

Ejemplares similares